Your institution may have access to this item. Find your institution then sign in to continue.
Title
Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis.
Authors
Zhu, B; Edson-Heredia, E; Cameron, G S; Shen, W; Erickson, J; Shrom, D; Wang, P; Banerjee, S; Gordon, K B
Abstract
Early identification of responsiveness to biologic treatments in psoriasis has significant clinical and economic implications.
Publication
The British journal of dermatology, 2013, Vol 169, Issue 6, p1337